Practice Fusion, a cloud-based EHR and patient medical record company, now has a warrant for $2.5 million from a long-term credit facility, according to a filing with the SEC.
The San Francisco-based startup, headed by CEO Ryan Howard, has more than 112,000 active monthly medical professionals with more than 91 million patient records, the company said. Last year, it launched a consumer-focused platform called Patient Fusion that lets individuals both schedule appointments and access their patient medical record.
Practice Fusion would not say if $2.5 million was the total amount of the long-term credit facility. This LTCF allows a company to generate capital over an extended time frame. These credit lines can be broken into multiple parts or used as collateral. The LTCF is often used in conjunction with other fundraising, but Practice Fusion would not say if this was how the LTCF was being used.
Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
Recently, Practice Fusion announced a partnership with three healthcare organizations in Puerto Rico — ASSERTUS, Atlantic Pathology and HRP Labs.